ULS vs PACS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 29, 2026

ULS

50.3
AI Score
VS
PACS Wins

PACS

59.8
AI Score

Investment Advisor Scores

ULS

50score
Recommendation
HOLD

PACS

60score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric ULS PACS Winner
Forward P/E 24.8756 15.528 PACS
PEG Ratio 1.3294 1.0347 PACS
Revenue Growth 5.2% 9.1% PACS
Earnings Growth 168.9% 51.6% ULS
Tradestie Score 50.3/100 59.8/100 PACS
Profit Margin 16.1% 4.9% ULS
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY PACS

Relative Price Performance (Last 90 Days)

ULS 1M: -9.5% · 3M: -31.4% PACS 1M: -2.6% · 3M: -7.8%

Current Technical Phase

ULS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.0%), weak momentum, RSI 38

RSI (14): 38.0 · Price: $66.50

PACS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.9%), weak momentum, RSI 40

RSI (14): 40.4 · Price: $41.03

Fundamentals Snapshot

Metric ULS PACS
Market Cap — —
Forward P/E 25.6 15.1
Trailing P/E 26.5 24.3
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.5% 0.2%
Operating Margin 0.2% 0.1%
EPS 2.48 1.71
Dividend Yield 0.01% —

Frequently Asked Questions

Based on our detailed analysis, PACS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.